ES2061942T3 - Composicion farmaceutica util para el tratamiento de enfermedades cardiovasculares. - Google Patents

Composicion farmaceutica util para el tratamiento de enfermedades cardiovasculares.

Info

Publication number
ES2061942T3
ES2061942T3 ES89201830T ES89201830T ES2061942T3 ES 2061942 T3 ES2061942 T3 ES 2061942T3 ES 89201830 T ES89201830 T ES 89201830T ES 89201830 T ES89201830 T ES 89201830T ES 2061942 T3 ES2061942 T3 ES 2061942T3
Authority
ES
Spain
Prior art keywords
treatment
pharmaceutical composition
cardiovascular diseases
composition useful
hypertension
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89201830T
Other languages
English (en)
Inventor
Cesare Casagrande
Luciano Licciardello
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zambon Group SpA
Zambon SpA
Original Assignee
Zambon Group SpA
Zambon SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Group SpA, Zambon SpA filed Critical Zambon Group SpA
Application granted granted Critical
Publication of ES2061942T3 publication Critical patent/ES2061942T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)

Abstract

SE DESCRIBE UNA COMPOSICION FARMACEUTICA QUE CONTIENE IBOPAMINA Y UN INHIBIDOR DE ACE. TAL COMPOSICION ES UTIL EN EL TRATAMIENTO DE ENFERMEDADES CARDIOVASCULARES, MAS ESPECIALMENTE DE HIPERTENSION, E INSUFICIENCIA DEL CORAZON, AUNQUE LA ULTIMA SE ASOCIA CON, O ES CAUSADA POR HIPERTENSION.
ES89201830T 1988-07-15 1989-07-11 Composicion farmaceutica util para el tratamiento de enfermedades cardiovasculares. Expired - Lifetime ES2061942T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8821369A IT1226796B (it) 1988-07-15 1988-07-15 Composizione farmaceutica utile per il trattamento di malattie cardiovascolari.

Publications (1)

Publication Number Publication Date
ES2061942T3 true ES2061942T3 (es) 1994-12-16

Family

ID=11180785

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89201830T Expired - Lifetime ES2061942T3 (es) 1988-07-15 1989-07-11 Composicion farmaceutica util para el tratamiento de enfermedades cardiovasculares.

Country Status (7)

Country Link
US (2) US5304570A (es)
EP (1) EP0351017B1 (es)
JP (1) JPH0296564A (es)
AT (1) ATE100332T1 (es)
DE (1) DE68912432T2 (es)
ES (1) ES2061942T3 (es)
IT (1) IT1226796B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080182859A1 (en) * 2006-11-02 2008-07-31 Curis, Inc. Small organic molecule regulators of cell proliferation
US20080194637A1 (en) * 2006-11-02 2008-08-14 Curis, Inc. Small organic molecule regulators of cell proliferation
WO2008057468A1 (en) * 2006-11-02 2008-05-15 Curis, Inc. Small organic molecule regulators of cell proliferation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1074038B (it) * 1976-08-05 1985-04-17 Simes Esteri della epinina
IT7851510A0 (it) * 1977-10-28 1978-10-16 Sandoz Ag Ammidi di amminoacidi ciclici loro preparazione e loro applicazione quali medicamenti
US4698356A (en) * 1979-08-14 1987-10-06 University Of Miami Anti-hypertensive agents
US4677102A (en) * 1986-02-07 1987-06-30 Merck & Co., Inc. Substituted diazapines and derivatives thereof useful in the treatment of cardiovascular disorders
FR2607004B1 (fr) * 1986-11-20 1990-06-01 Synthelabo Compositions pharmaceutiques contenant du diltiazem et un inhibiteur de l'enzyme de conversion de l'angiotensine

Also Published As

Publication number Publication date
ATE100332T1 (de) 1994-02-15
DE68912432T2 (de) 1994-08-11
IT1226796B (it) 1991-02-19
EP0351017A3 (en) 1990-05-30
US5571834A (en) 1996-11-05
US5304570A (en) 1994-04-19
DE68912432D1 (de) 1994-03-03
JPH0296564A (ja) 1990-04-09
EP0351017A2 (en) 1990-01-17
IT8821369A0 (it) 1988-07-15
EP0351017B1 (en) 1994-01-19

Similar Documents

Publication Publication Date Title
ES2150663T3 (es) Tratamiento de la incontinencia urinaria utilizando (s)-oxibutinina y (s)-desetiloxibutinina.
AR002254A1 (es) Formulacion antitrombotica y procedimiento para su manufactura
LV10050A (lv) Farmaceitiska kompozicija ar zemam orala antikoagulanta un trombocitu inhibitora devam
YU47204B (sh) Derivati didehidro-vitamina d3
KR870005637A (ko) 약물 데포
ATE77557T1 (de) Zusammensetzung zur erhoehung der intrazell-atpspiegel und des physischen leistungsniveaus und zur erhoehung der geschwindigkeit von wundenheilung.
ES2196190T3 (es) Inhibidores de metaloproteinasas matriciales, con hidroxamato bifenlico.
MX9304435A (es) Compuesto y composicion farmaceutica para el tratamiento y la profilaxis de la obesidad o para el tratamiento de la diabetes del tipo ii.
AR246755A1 (es) Una composicion para el tratamiento de las superficies de los suelos.
FI865159A0 (fi) Kompositioner som innehaoller en stabiliserad aktivator foer maenniskans vaevnadsplasminogen.
DK0424028T3 (da) S(+)-ibuprofen-L-aminosyre og S(+)-ibuprofen-D-aminosyre som et forbedret smertestillende middel med fremskyndet indtrædelse
DE69034070D1 (de) Racemisches Huperzin A
ES2047033T3 (es) Un metodo para preparar compuestos de hidroxivitamina d.
MX9203787A (es) Composicion farmaceutica que contiene un portador farmaceuticamente adecuado y el compuesto que contiene la estructura (7 alfa, 17 alfa)-17-hidroxi-7-metil-19-nor-17-pregn-5(10)-en 20-in-3-ona.
PT90743A (pt) Processo para a preparacao de derivados de hirudina com accao retardada e de composicoes farmaceuticas que os contem
DK412788A (da) Farmaceutisk middel til brug ved behandling af uraemi
ES2057262T3 (es) Derivados del cromano.
ES2061942T3 (es) Composicion farmaceutica util para el tratamiento de enfermedades cardiovasculares.
ES2187534T3 (es) Procedimiento para la preparacion de n-metil-3-(metil-4-piperi dinil)-14-indol-5-etanosulfonamida.
ES2051809T3 (es) Un procedimiento para preparar una composicion farmaceutica.
ITMI920608A1 (it) Derivati della 2-ammino-tetralina attivi sul sistema cardiovascolare
AR019724A2 (es) Composicion farmaceutica util para el tratamiento de diabetes mellitus y condiciones asociadas
ES2099865T3 (es) Ciclopentanoperhidrofenantreno-17beta-(3-furil)-3-derivados y composiciones farmaceuticas que comprenden los mismos para el tratamiento de trastornos cardiovasculares.
PT90127A (pt) Processo para a preparacao de composicoes farmaceuticas com accao analgesica que contem 4-aril-4-piperidino (ou pirrolidino ou hexa-hidroazepino)-carbinois ou os seus analogos heterociclicos
ES2033181B1 (es) Una tableta o capsula de herbicida para su aplicacion en arrozales.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 351017

Country of ref document: ES